BECA, J.; MAJEED, H.; CHAN, K. K.; HOTTE, S. J.; LOBLAW, A.; HOCH, J. S. Cost-effectiveness of docetaxel in high-volume hormone-sensitive metastatic prostate cancer. Canadian Urological Association Journal, [S. l.], v. 13, n. 12, p. 396–403, 2019. DOI: 10.5489/cuaj.5889. Disponível em: https://cuaj.ca/index.php/journal/article/view/5889. Acesso em: 19 apr. 2024.